Combination of Transcranial Magnetic Stimulation with Electromyography and Electroencephalography: Application in Diagnosis of Neuropsychiatric Disorders
“…Despite the above‐mentioned in vitro findings, studying GABA in vivo has been more difficult than other neurotransmitters, such as dopamine and serotonin, which can be studied through PET imaging techniques 26 . However, recent advances in multimodal neurophysiological techniques such as TMS combined with EEG 27–29 and magnetic resonance spectroscopy (MRS), 30 which permit in vivo examination of GABAergic neurotransmission and GABA concentration in various cortical regions in humans, are now rapidly expanding our understanding of the role of GABAergic neurotransmission in the pathophysiology of schizophrenia.…”
Section: Evidence For Gabaergic Deficits In Patients With Schizophreniamentioning
Cognitive dysfunction is suggested to be the best predictor of functional outcome in schizophrenia. Therefore, new diagnostic and treatment strategies are needed to both ascertain the biological underpinning of cognitive deficits and to restore them. Modulation of gamma oscillations (30-50 Hz) has been associated with cognitive performance, particularly in the dorsolateral prefrontal cortex (DLPFC). In this manuscript, we review evidence for gamma modulation deficits during cognitive performance in schizophrenia. We demonstrate that transcranial magnetic stimulation (TMS) combined with electroencephalography (EEG) is a reliable method that permits systematic quantification of gamma modulation in the cortex. Using TMS-EEG, we show that patients with schizophrenia have selective gamma inhibition deficits in the DLPFC. Finally, we demonstrate that repetitive TMS therapy over the DLPFC can normalize excessive gamma oscillations and ultimately cognitive performance in patients. We suggest that restoring gamma impairments in the DLPFC may be a potential strategy for improving cognitive deficits in schizophrenia.
“…Despite the above‐mentioned in vitro findings, studying GABA in vivo has been more difficult than other neurotransmitters, such as dopamine and serotonin, which can be studied through PET imaging techniques 26 . However, recent advances in multimodal neurophysiological techniques such as TMS combined with EEG 27–29 and magnetic resonance spectroscopy (MRS), 30 which permit in vivo examination of GABAergic neurotransmission and GABA concentration in various cortical regions in humans, are now rapidly expanding our understanding of the role of GABAergic neurotransmission in the pathophysiology of schizophrenia.…”
Section: Evidence For Gabaergic Deficits In Patients With Schizophreniamentioning
Cognitive dysfunction is suggested to be the best predictor of functional outcome in schizophrenia. Therefore, new diagnostic and treatment strategies are needed to both ascertain the biological underpinning of cognitive deficits and to restore them. Modulation of gamma oscillations (30-50 Hz) has been associated with cognitive performance, particularly in the dorsolateral prefrontal cortex (DLPFC). In this manuscript, we review evidence for gamma modulation deficits during cognitive performance in schizophrenia. We demonstrate that transcranial magnetic stimulation (TMS) combined with electroencephalography (EEG) is a reliable method that permits systematic quantification of gamma modulation in the cortex. Using TMS-EEG, we show that patients with schizophrenia have selective gamma inhibition deficits in the DLPFC. Finally, we demonstrate that repetitive TMS therapy over the DLPFC can normalize excessive gamma oscillations and ultimately cognitive performance in patients. We suggest that restoring gamma impairments in the DLPFC may be a potential strategy for improving cognitive deficits in schizophrenia.
“…TMS-EEG complements the H-reflexes and the invasive epidural recordings and permits revisiting the classical TMS-EMG paradigms and delineating, with more precision, neural processes that underlie the MEP modification at the periphery. Thus, a growing number of TMS-EEG studies have begun to document the EEG correlates of single and paired pulse TMS paradigms in the motor cortex at rest (Ilmoniemi et al, 1997, Paus et al, 2001, Nikulin et al, 2003, Komssi and Kahkonen, 2006, Farzan et al, 2010c, Farzan et al, 2010a, Farzan et al, 2010b, Ferreri et al, 2011; reviewed in Farzan et al, 2011). However, the EEG correlates of the TMS induced SP have not been described.…”
Application of magnetic or electrical stimulation to the motor cortex can result in a period of electromyography (EMG) silence in a tonically active peripheral muscle. This period of EMG silence is referred to as the silent period (SP). The duration of SP shows intersubject variability and reflects the integrity of cortical and corticospinal pathways. A non-invasive technique for assessing the duration of SP is the combination of Transcranial Magnetic Stimulation (TMS) with EMG. Utilizing TMS-EMG, several studies have reported on the shortening or lengthening of SP in neuropsychiatric disorders such as schizophrenia, bipolar disorder, depression, obsessive compulsive disorder, epilepsy, Parkinson’s disease, and stroke. However, cortical, corticospinal and peripheral components are difficult to disentangle from EMG alone. Here, we use the multimodal neuroimaging technique of TMS-EMG combined with concurrent electroencephalography (EEG) recording to further examine the cortical origin of SP and the cortical oscillatory activity that underlies SP genesis. We demonstrate that the duration of SP is related to the temporal characteristics of the cortical reactivity and the power of delta to alpha oscillations in both local and remote areas ipsilateral and contralateral to the stimulation site, and beta oscillations locally. We illustrate that, compared to EMG, the EEG indices of the SP provide additional information about the brain dynamics and propose that the EEG measures of SP may be used in future clinical and research investigations to more precisely delineate the mechanisms underlying inhibitory impairments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.